Page 75

APPENDIX B

March 8, 2001
Meeting Agenda

IMMUNIZATION SAFETY REVIEW COMMITTEE MEASLES-MUMPS-RUBELLA VACCINE AND AUTISM MEETING

National Academies Building

2101 Constitution Ave., NW

Washington, D.C.

SESSION I: ETIOLOGY, DIAGNOSIS, AND EPIDEMIOLOGY OF AUTISM

8:30–8:35 a.m.

Opening Remarks

Marie McCormick, M.D., Sc.D., Chair, Immunization Safety Review Committee

8:35–9:00 a.m.

Neurobiology and Neuropathology of Autism

Thomas Kemper, M.D., Professor, Department of Neurology, Anatomy, and Pathology, Boston University School of Medicine

9:00–9:30 a.m.

Etiology of Autism and NIH Research

Marie Bristol-Power, Ph.D., Special Assistant on Autism, Office of the Director, National Institute of Child Health and Human Development, National Institutes of Health



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 75
Page 75 APPENDIX B March 8, 2001 Meeting Agenda IMMUNIZATION SAFETY REVIEW COMMITTEE MEASLES-MUMPS-RUBELLA VACCINE AND AUTISM MEETING National Academies Building 2101 Constitution Ave., NW Washington, D.C. SESSION I: ETIOLOGY, DIAGNOSIS, AND EPIDEMIOLOGY OF AUTISM 8:30–8:35 a.m. Opening Remarks Marie McCormick, M.D., Sc.D., Chair, Immunization Safety Review Committee 8:35–9:00 a.m. Neurobiology and Neuropathology of Autism Thomas Kemper, M.D., Professor, Department of Neurology, Anatomy, and Pathology, Boston University School of Medicine 9:00–9:30 a.m. Etiology of Autism and NIH Research Marie Bristol-Power, Ph.D., Special Assistant on Autism, Office of the Director, National Institute of Child Health and Human Development, National Institutes of Health

OCR for page 75
Page 76 9:30–10:00 a.m. Diagnosis and Assessment of Autism Fred Volkmar, M.D., Professor of Child Psychiatry, Pediatrics, and Psychology, Yale Child Study Center 10:15–10:45 a.m. Epidemiological Evidence on Rates of Autism and Time Trends Eric Fombonne, M.D., FRCPsych, Reader in Epidemiological Child Psychiatry, Institute of Psychiatry, King's College London 10:45–11:00 a.m. Trends in Students with Autism in IDEA Programs Louis Danielson, Ph.D., Director of Research to Practice Division, Office of Special Education Programs, Department of Education 11:00–11:45 a.m. Discussion Panel Kathryn Carbone, M.D., Chief, Laboratory of Pediatric and Respiratory Viral Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration Karin Nelson, M.D., Senior Investigator, Neuroepidemiology Branch, National Institute for Neurological Disorders and Stroke, National Institutes of Health Ezra Susser, M.D., Head, Division of Epidemiology, Joseph L. Mailman School of Public Health, Columbia University SESSION II: MMR AND AUTISM HYPOTHESIS 12:30–1:30 p.m. Hypothesis and Data Linking MMR, Bowel Symptoms and Autism Andrew Wakefield, M.D., Royal Free & University College Medical School, United Kingdom Kenneth Aitken, Ph.D., Independent Consultant Child Clinical Neuropsychologist 1:30–2:00 p.m. Overview of Epidemiological Studies Examining Potential Link Between MMR, Bowel Symptoms, and Autism Michael Stoto, Ph.D., Chair, Department of Epidemiology and Biostatistics, George Washington University 2:00–2:30 p.m. New Data and Research Findings Regarding a Potential Link Between MMR, Bowel Symptoms, and Autism

OCR for page 75
Page 77   Eric Fombonne, M.D., FRCPsych, Reader in Epidemiological Child Psychiatry, Institute of Psychiatry, King's College London 2:45–4:00 p.m. Discussion Panel Scott Montgomery, Ph.D., Karolinska Institute, Sweden Brian Ward, M.D., Associate Professor, Medicine & Microbiology, McGill University and Montreal General Hospital Research Institute Michael Gershon, M.D., Professor and Chair, Department of Anatomy and Cell Biology, Columbia University Kathryn Carbone, M.D., Chief, Laboratory of Pediatric and Respiratory Viral Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration Karin Nelson, M.D., Senior Investigator, Neuroepidemiology Branch, National Institute for Neurological Disorders and Stroke, National Institutes of Health 4:00–4:15 p.m. Study of Autism and the Vaccine Adverse Event Reporting System (VAERS) Jane Woo, M.D., M.P.H., Fellow, Vaccine Safety Branch, Division of Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration 4:15–5:00 p.m. Public Comment Session

OCR for page 75
Page 78